764038 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
165 Generating enhanced tumor infiltrating lymphocytes through microfluidic cell squeezing |
2021-11-01 |
10.1136/jitc-2021-sitc2021.165 |
Bridgen Devin, Bhattacharjee Arindam, Thalhofer Colin, Montler Ryan, Weinberg Andrew, Sharei Armon, Gilbert Jonathan |
764037 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
157 Lymph node targeted boosting with cognate amphiphile-peptide vaccines enhances TCR-T Cell therapy to eradicate solid tumors |
2021-11-01 |
10.1136/jitc-2021-sitc2021.157 |
Drakes Dylan, Abbas Abdulraouf, Shields Jacqueline, DeMuth Peter |
764036 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
154 Context-dependent reversible modulation of cJUN expression by CAR T cells for cancer treatment |
2021-11-01 |
10.1136/jitc-2021-sitc2021.154 |
Yang Zhifen, Marincola Francesco |
764035 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
153 Nanoscale, antigen-dependent, IL-12 delivery by CAR T cells plus PD-L1 blockade for cancer treatment |
2021-11-01 |
10.1136/jitc-2021-sitc2021.153 |
Yang Zhifen, Marincola Francesco |
764034 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
151 Potentiating the Large-Scale Expansion and Engineering of Peripheral Blood-Derived CAR NK Cells for Off-the-Shelf Application |
2021-11-01 |
10.1136/jitc-2021-sitc2021.151 |
Whang Michael, Xie Ming-Hong, Jamboretz Kate, Lemar Hadia, Guo Chao, Rahman Nafees, Chan Ivan, Whiteley Erik, Brandenberger Ralph, Lazetic Sasha, Trager James |
764033 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
147 Memory phenotype in allogeneic anti-BCMA CAR-T cell therapy (P-BCMA-ALLO1) correlates with in vivo tumor control |
2021-11-01 |
10.1136/jitc-2021-sitc2021.147 |
Tseng Hubert, Zhang Yan, Cranert Stacey, Richter Maximilian, Marquez Karl, Qiu Jing, Cho Benjamin, Tan Yening, Tong Min, Domingo Christine, Weiss Leslie, Argus Elvira, Sparks Jessica, Ostertag Eric, Coronella Julia, Shedlock Devon |
764032 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
146 Evolving Mutliplexed shRNA to generate tailored CAR T cell therapy |
2021-11-01 |
10.1136/jitc-2021-sitc2021.146 |
Steklov Mikhail, Lecalve Benjamin, Marijse Jerome, Huberty Fanny, Ramelot Nancy, Jacques-Hespel Celine, Iserentant Hannes, Breman Eytan, Gilham David |
764031 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
145 Comparison of CAR-T cell manufacturing platforms reveals distinct phenotypic and transcriptional profiles |
2021-11-01 |
10.1136/jitc-2021-sitc2021.145 |
Song Hannah, Shao Lipei, Prochazkova Michaela, Cheuk Adam, Jin Ping, Stroncek David, Khan Javed, Highfill Steven |
764030 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
144 SIRPα deficient CAR-Macrophages exhibit enhanced anti-tumor function and bypass the CD47 immune checkpoint |
2021-11-01 |
10.1136/jitc-2021-sitc2021.144 |
Sloas Chris, Gabbasov Rashid, Anderson Nicholas, Abramson Sascha, Klichinsky Michael, Ohtani Yumi |
764029 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
143 Mesothelin (MSLN) targeting allogeneic CAR T cells engineered to overcome tumor immunosuppressive microenvironment |
2021-11-01 |
10.1136/jitc-2021-sitc2021.143 |
Schiffer-Mannioui Cecile, Leduc Sophie, Chion-Sotinel Isabelle, Clerre Diane le, Guyot Valérie, Rotondi Marco, Galetto Roman, Gouble Agnès |